221
Participants
Start Date
March 8, 2016
Primary Completion Date
January 9, 2017
Study Completion Date
January 30, 2017
FDC of tiotropium + olodaterol
Fixed Dose Combination of tiotropium + olodaterol
Placebo
Tiotropium
Olodaterol
Arjana Macek d.o.o., Ljubljana
Verboten Kopriva Renata - Private practice, Litija, Litija
Hvidovre Hospital, Hvidovre
KH d. Elisabethinen Linz, Linz
Univ. Clinic of Respiratory and Allergic Diseases, Golnik, Golnik
Aarhus Universitetshospital, Aarhus
Ordination Dr. Robert Voves, 8330 Feldbach, Feldbach
Regionshospitalet Silkeborg, Silkeborg
TYKS, Keuhkosairauksien klinikka, Turku, Turku
CAB Dupouy J, Pneumo, Nîmes, Nîmes
HOP Haut-Lévêque, Pessac
CLI du Parc, Pneumo, Castelnau le Lez, Castelnau-le-Lez
HOP Maison Blanche, Reims
CAB Lejay D, MG, Vieux Condé, Vieux-Condé
HOP Louis Pradel, Bron
HOP Cochin, Paris
Jorvin sairaala, Espoo
HYKS Keuhkosairauksien, Helsinki
TAYS, Keuhkotautien poliklinikka, Tampere
Terveystalo Pulssi, Turku, Turku
CAB Pigearias B., Pneumo, Nice, Nice
INS A.Tzanck,Pneumo,St Laurent du Var, Saint-Laurent-du-Var
Lead Sponsor
Boehringer Ingelheim
INDUSTRY